People with asthma face a measurably higher risk of developing systemic lupus erythematosus, and people already living with lupus are more likely to have asthma than the general population. A meta-analysis pooling data from several studies found that asthma patients had about 37 percent greater odds of developing lupus compared with people without asthma. The relationship runs deeper than a statistical coincidence: the two conditions share molecular signaling pathways, respond to some of the same immune triggers, and can complicate each other’s treatment in ways that matter for everyday quality of life.
How Often Do Lupus and Asthma Overlap?
Asthma shows up in lupus patients at rates well above the general population. A large epidemiological study found that roughly 10.6 percent of people with lupus also had asthma, compared with about 7.6 percent of matched individuals without lupus.1PubMed Central. Atopic Diseases and Systemic Lupus Erythematosus: An Epidemiological Study of the Risks and Correlations That gap might not look dramatic in raw percentages, but it was consistent across different atopic conditions, including allergic rhinitis and eczema, suggesting a broad tendency toward allergic disease in lupus patients rather than a fluke in one subgroup.
A systematic review and meta-analysis confirmed this pattern from the opposite direction, finding that people with asthma had a pooled odds ratio of 1.37 for developing lupus.2PubMed. Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta-analysis In practical terms, the association is real and statistically robust, but it is modest. Having asthma does not mean lupus is likely, and having lupus does not guarantee asthma. The overlap is more meaningful at the population level and for researchers trying to understand shared immune pathways than it is as a predictor for any individual patient.
Data from large patient registries paint a starker picture in certain settings. In one U.S.-based lupus cohort, nearly 20 percent of participants reported having asthma at enrollment, roughly double the national average.3PubMed Central. The Impact of Asthma and Chronic Obstructive Pulmonary Disease (COPD) on Patient-Reported Outcomes in Systemic Lupus Erythematosus (SLE) Self-reported rates can run higher than insurance-claims data, but the direction is consistent across every dataset that has looked at this question.
What the Immune System Is Doing in Both Conditions
Lupus and asthma seem like they should be opposites. Lupus is an autoimmune disease, where the immune system attacks the body’s own tissues. Asthma is typically allergic, driven by an exaggerated response to outside triggers like pollen or dust mites. In immunology textbooks, autoimmunity and allergy are described as going in different directions. But the human immune system is messier than textbooks suggest, and the two conditions share more wiring than their opposing labels imply.
One point of convergence is immunoglobulin E, the antibody best known for driving allergic reactions. IgE levels are significantly elevated during active lupus flares, suggesting that this “allergy antibody” plays a role in lupus pathology too, particularly when the disease is at its most aggressive.4Mediators of Inflammation. Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients IgE can bind to self-antigens in lupus, not just the environmental allergens it targets in asthma. This is one reason why a drug originally developed for allergic asthma has been tested in lupus patients, a topic explored further below.
At a deeper molecular level, a bioinformatics study comparing gene expression in lupus and asthma identified 147 genes that were changed in the same direction in both diseases. The gene STAT3, a regulator of inflammation and immune cell behavior, emerged as the central hub connecting these shared changes. The upregulated genes mapped onto innate immune pathways involved in pathogen sensing and the formation of neutrophil extracellular traps, structures that are implicated in tissue damage during lupus flares. The downregulated genes pointed to disrupted adaptive immunity, including problems with natural killer cell function and the differentiation of T-helper cells.5Scientific Reports. Identification of STAT3 signaling as a shared pathogenic signature in systemic lupus erythematosus, chronic obstructive pulmonary disease, and asthma In plain terms, the two diseases share a set of molecular switches that push the immune system toward chronic inflammation, even though the clinical results look very different in the airways versus, say, the kidneys or skin.
A Genetic Twist That Cuts Both Ways
One of the more surprising findings in this area involves genes that increase the risk of one condition while appearing to protect against the other. A genome-wide study identified a variant in the TNIP1 gene where the version that reduces asthma risk is actually the version that raises the risk of lupus and other autoimmune diseases.6PubMed Central. Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases TNIP1 helps regulate a major inflammatory signaling pathway, and the direction in which it tilts that pathway determines whether the immune system leans more toward allergy or autoimmunity.
This finding helps explain why the overlap between lupus and asthma exists but remains moderate. The genetic architecture of the two conditions sometimes pushes in opposite directions, meaning that getting both requires a particular combination of risk variants that does not line up neatly. It also hints at why treatments that suppress one branch of the immune system can occasionally unmask or worsen the other: dampening the autoimmune arm might leave the allergic arm less restrained, or vice versa.
How Asthma Makes Lupus Harder to Live With
For people who have both conditions, the practical burden is more than additive. In a longitudinal lupus cohort, patients with coexisting asthma reported greater worsening of fatigue, pain, and overall health ratings over time compared with lupus patients who did not have asthma.7PubMed Central. The Impact of Asthma and Chronic Obstructive Pulmonary Disease (COPD) on Patient-Reported Outcomes in Systemic Lupus Erythematosus (SLE) Fatigue is already one of the most debilitating symptoms of lupus, and adding chronic airway inflammation to the mix intensifies it. Breathlessness and exercise intolerance from asthma can further limit physical activity, which is one of the few non-drug interventions that helps manage lupus fatigue.
The diagnostic picture gets murkier too. Lupus itself causes lung problems, including pleuritis, interstitial lung disease, and a rare condition called shrinking lung syndrome. When someone with lupus also has asthma, clinicians must work out whether worsening breathlessness is from asthma flaring, lupus attacking the lungs directly, an infection related to immunosuppressive treatment, or some combination. The symptom overlap means that a simple peak-flow reading or spirometry result can mislead if it is interpreted without the full clinical context.
Why This Matters More in Children
The interaction between atopic disease and lupus appears to be especially consequential in pediatric patients. A study of 80 children newly diagnosed with juvenile lupus divided them into those with and without atopy, which included asthma, eczema, and allergic rhinitis. The atopic group had significantly more severe disease at diagnosis: higher disease activity scores, faster sedimentation rates, lower complement levels, and altered immune cell profiles including fewer natural killer cells. Over the following two years, the atopic children experienced more than twice as many disease flares and took roughly two extra months to reach a stable condition compared to the non-atopic group.8PLOS ONE. Atopy in children with juvenile systemic lupus erythematosus is associated with severe disease
These numbers are striking because they suggest that atopy is not just a bystander in childhood lupus but an active contributor to worse outcomes. Whether this is because the allergic immune response adds fuel to the autoimmune fire, or because the two share an underlying immune dysregulation that makes both worse, remains an open question. Either way, pediatric rheumatologists may want to pay closer attention to a child’s allergy history when planning lupus treatment.
Separately, research on exhaled nitric oxide in children with lupus has found a meaningful correlation between airway inflammation levels and lupus disease activity, even in children not diagnosed with asthma. Children with active lupus also showed a progressive decline in lung capacity over follow-up, with restrictive lung defects increasing from about 21 percent at baseline to 29 percent.9PubMed. Exhaled nitric oxide, pulmonary function, and disease activity in children with systemic lupus erythematosus The airways seem to be a sensitive barometer of systemic inflammation in young lupus patients, which makes monitoring lung function more important than it might otherwise seem in a disease that is primarily thought of in terms of joints, skin, and kidneys.
The Steroid Problem
Corticosteroids are a mainstay of treatment for both lupus flares and asthma exacerbations, and this shared reliance creates a particular challenge for patients with both conditions. Short bursts of oral steroids can control an asthma attack or tamp down a lupus flare, but long-term systemic steroid use carries a heavy price. A systematic literature review found that commonly cited side effects of chronic corticosteroid exposure included high blood pressure in more than 30 percent of patients, bone fractures in roughly a fifth to a third, cataracts, gastrointestinal problems, and metabolic complications like weight gain and type 2 diabetes, with cases having about four times the risk of diabetes compared to controls.10PubMed. Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review
For someone with both lupus and asthma, the cumulative steroid burden adds up fast. A lupus flare might require weeks of oral prednisone, and if an asthma exacerbation hits during that period, the total dose climbs further. Clinicians managing both conditions in the same patient tend to push hard for steroid-sparing strategies: inhaled corticosteroids for asthma control so that systemic doses can be reserved for lupus, and lupus-specific immunosuppressants to reduce how often oral steroids are needed.
Treatment Crossover and Emerging Options
Some drugs used for lupus have shown benefit in severe asthma, and at least one asthma drug is being explored in lupus, creating an unusual treatment crossover. Mycophenolate mofetil, an immunosuppressant widely used in lupus nephritis, has been tried in cases of treatment-resistant asthma. A case series described its use in patients whose asthma did not respond to standard therapies. However, the drug comes with notable side effects: about a quarter of patients on mycophenolate for lupus nephritis stop it due to adverse reactions, and upper respiratory infections affect roughly a third.11European Respiratory Journal. Case series reporting the effectiveness of mycophenolate mofetil in treatment-resistant asthma For someone with both conditions, the idea of a single drug pulling double duty is appealing, but the side-effect profile means it is far from a default choice.
The more intriguing crossover runs in the other direction. Omalizumab, a biologic originally developed to block IgE in allergic asthma, has been tested in a small randomized trial of patients with mild-to-moderate lupus and elevated autoreactive IgE. Patients receiving the drug showed a statistically significant improvement in lupus disease activity scores compared with placebo over 16 weeks, and the drug was well tolerated.12PubMed Central. Allergic reactions in systemic lupus erythematosus: From pathogenic pathways to clinical practice The average improvement was small, about a 2-point reduction on a standard activity index, which raises questions about whether the effect is clinically meaningful. But for patients who already take omalizumab for asthma and also have lupus, the possibility that it could help both conditions is worth watching as larger trials are designed.
The Gut Microbiome as a Shared Player
Both lupus and asthma are increasingly being studied through the lens of the gut microbiome, the community of bacteria and other microorganisms living in the digestive tract. Disruptions in the gut microbiome, sometimes called dysbiosis, have been linked to both conditions as part of a broader pattern in chronic inflammatory diseases. A narrative review covering lupus, asthma, inflammatory bowel disease, rheumatoid arthritis, psoriasis, and vasculitis highlighted that all six diseases share features of immune dysregulation tied to shifts in gut microbial composition, and discussed microbiota-based therapies such as fecal microbiota transplant, dietary changes, and probiotic interventions as potential treatments.13PubMed Central. Gut Microbiome and Immune System Crosstalk in Chronic Inflammatory Diseases: A Narrative Review of Mechanisms and Therapeutic Opportunities
The practical upshot for patients with both conditions is still speculative. No one is prescribing a specific probiotic for lupus-with-asthma based on current evidence. But the observation that the same microbial imbalances contribute to both diseases reinforces the idea that they are not unrelated conditions that happen to coexist. They may share a common soil in the gut that, if it could be modified, might improve both at once. Research here is early but worth keeping an eye on.
Stress and the Immune Feedback Loop
Chronic psychological stress is a recognized aggravator of both lupus flares and asthma exacerbations, and the mechanism is partly shared. Prolonged stress increases pro-inflammatory cytokines and disrupts immune balance, worsening autoimmune diseases and allergic conditions alike.14International Journal of Medical Reviews. Relationship between Stress and the Immune System-related Disorders For someone managing both lupus and asthma, this creates a feedback loop: a lupus flare causes pain, fatigue, and worry about organ damage; the stress from managing the flare can trigger asthma symptoms; worsening breathing increases anxiety, which raises cortisol and inflammatory markers, which can provoke more lupus activity. Breaking this cycle is one reason why lupus treatment guidelines increasingly acknowledge the role of mental health support and stress management alongside conventional immunosuppressive therapy.
Rare Overlaps and the Eosinophilic Spectrum
In rare cases, the overlap between lupus and asthma takes on an even more complex form. A published case report described a woman with a ten-year history of rheumatoid arthritis who subsequently developed lupus, confirmed by lab markers and clinical criteria, and then developed adult-onset asthma with chronic sinus disease and dramatically elevated eosinophil counts. Her presentation fell on the spectrum between eosinophilic granulomatosis with polyangiitis (formerly called Churg-Strauss syndrome) and hypereosinophilic asthma with systemic manifestations, a diagnostic borderland that challenges even experienced specialists.15PubMed Central. Case Report: Triple autoimmune overlap: rheumatoid arthritis, systemic lupus erythematosus, and hypereosinophilic asthma with systemic manifestations
This kind of triple overlap is unusual, but it illustrates something important about how autoimmune and allergic diseases interact. They do not occupy neatly separate boxes. The same patient can have immune dysregulation operating through multiple channels simultaneously, and the boundaries between “autoimmune” and “allergic” can blur in practice. For clinicians, the case reinforces the need to investigate new respiratory symptoms in lupus patients rather than assuming they are straightforward asthma, particularly when eosinophil counts are very high or when standard asthma treatment is not working as expected.
Respiratory Viruses as a Shared Trigger
Respiratory viral infections sit at a crossroads between asthma and autoimmunity. Viruses can trigger asthma exacerbations directly by inflaming the airways, and they have also been implicated in the development of autoimmune conditions through a process known as heterologous immunity, where the immune response to one pathogen accidentally targets the body’s own tissues. A review of this phenomenon noted that respiratory viruses contribute to both asthma worsening and autoimmune disease development, while paradoxically, a lack of microbial exposure is associated with rising rates of both allergic and autoimmune diseases.16Allergo Journal International. Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?
For someone with both lupus and asthma, a common cold is not just a nuisance. It can simultaneously inflame the airways and provoke immune responses that risk a lupus flare. This is compounded by the fact that many lupus treatments suppress the immune system, making infections more likely to begin with. Staying current on vaccinations, practicing standard infection-prevention measures, and having a clear action plan for respiratory illness are all more important in this population than they might seem for someone managing either condition alone.